VINCRISTINE TEVA
1MG/ML INJ SOL 1X1ML
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Interruption of marketing | 31.08.2022 | Lék není nahraditelný | Commercial/marketing reasons | 30.09.2022 |
| Resumption of marketing | 07.01.2022 | |||
| Interruption of marketing | 31.01.2022 | Lék není nahraditelný | Manufacturing reasons | únor 2022 |
| Resumption of marketing | 16.07.2020 | |||
| Interruption of marketing | 13.05.2020 |
0011421 |
Manufacturing reasons | 30.06.2020 |
| Resumption of marketing | 01.08.2017 | |||
| Interruption of marketing | 01.06.2017 |
0011421 |
||
| Resumption of marketing | 20.01.2014 | |||
| Interruption of marketing | 15.10.2013 |
0011421 |
||
| Resumption of marketing | 16.04.2013 | |||
| Interruption of marketing | 21.03.2013 |
0011421, 0011422 |
All reports are available in the Overview.
cz